Prognostic Value of CD64 Marker for Patients in Intensive Care Unit

Clinical trial NCT03617796 · UNKNOWN

Trial details

NCT number: NCT03617796
Sponsor: Central Hospital, Nancy, France
Status: UNKNOWN
Study type: OBSERVATIONAL

Systemic Inflammatory Response Syndrome Intensive Care

Start date: 2018-09-10
Primary completion: 2018-12-09
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.